ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET FORECAST 2017-2026
KEY FINDINGS
The Asia-Pacific surgical and medical device market is expected to register a CAGR growth of 6.50% over the forecast period of 2017-2026, raising approximately $ 167205 million by the end of 2026.
MARKET INSIGHTS
Factors like thriving healthcare sector and rise in annual disposable income are highly aiding in the market expansion. The markets of China and India have made considerable progress over the years. The governments of both these countries are relaxing regulations related to the private investments in the surgical and medical device for pharmaceutical and medical industry which has considerably boosted the confidence of the several private players to invest in the Asia-Pacific medical device market. The Australian market is anticipated to evolve with the highest CAGR over the forecast period. The Australian healthcare system is a mixture of public and private sector health service providers with a range of funding and regulatory mechanisms for surgical and medical devices.
COMPETITIVE INSIGHTS
Toshiba Medical Systems Corp (Canon), Johnson & Johnson, Roche Diagnostics, Agilent Technologies, Novartis,Philips Healthcare, 3M Company, Ge Healthcare, Thermo Fisher Scientific, Zimmer Holdings, Abbott Laboratories, Siemens Healthcare, Cryolife Inc, Baxter International,Medtronic, Halyard Health Inc, Smith & Nephew, Danaher, Olympus Corporation, Cardinal Health, Endologix Inc, Stryker Corp and Depuy Synthes are some of the well-known companies in the Asia-Pacific market.
The Asia-Pacific surgical and medical device market is expected to register a CAGR growth of 6.50% over the forecast period of 2017-2026, raising approximately $ 167205 million by the end of 2026.
MARKET INSIGHTS
Factors like thriving healthcare sector and rise in annual disposable income are highly aiding in the market expansion. The markets of China and India have made considerable progress over the years. The governments of both these countries are relaxing regulations related to the private investments in the surgical and medical device for pharmaceutical and medical industry which has considerably boosted the confidence of the several private players to invest in the Asia-Pacific medical device market. The Australian market is anticipated to evolve with the highest CAGR over the forecast period. The Australian healthcare system is a mixture of public and private sector health service providers with a range of funding and regulatory mechanisms for surgical and medical devices.
COMPETITIVE INSIGHTS
Toshiba Medical Systems Corp (Canon), Johnson & Johnson, Roche Diagnostics, Agilent Technologies, Novartis,Philips Healthcare, 3M Company, Ge Healthcare, Thermo Fisher Scientific, Zimmer Holdings, Abbott Laboratories, Siemens Healthcare, Cryolife Inc, Baxter International,Medtronic, Halyard Health Inc, Smith & Nephew, Danaher, Olympus Corporation, Cardinal Health, Endologix Inc, Stryker Corp and Depuy Synthes are some of the well-known companies in the Asia-Pacific market.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. DRUG DELIVERY DEVICES HOLDS THE LARGEST MARKET SHARE IN TERMS OF TECHNOLOGY
3.2.2. AMBULATORY SURGERY CENTERS (ASC) ARE THE MARKET LEADERS IN TERMS OF END USERS
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. PROLONGED LIFE EXPECTANCY
4.1.2. INCREASE IN DEMAND FOR MEDICAL DEVICE TECHNOLOGIES
4.1.3. LEGISLATIVE ALTERATIONS AND OTHER INGENUITIES
4.2. MARKET RESTRAINTS
4.2.1. HIGH COSTS OF MEDICAL AND SURGICAL DEVICES
4.2.2. EXCISE DUTY ADDED TO THE COST OF MEDICAL DEVICES
5. MARKET SEGMENTATION
5.1. MARKET BY TECHNOLOGY 2017-2026
5.1.1. DRUG DELIVERY DEVICES
5.1.1.1. INFUSION SYSTEMS AND INJECTABLE
5.1.1.2. NEEDLE-FREE INJECTIONS/TRANSDERMAL SYSTEMS AND OTHERS
5.1.1.3. INHALATION SYSTEMS
5.1.2. UROLOGY AND RENAL
5.1.2.1. RENAL DIALYSIS DEVICES
5.1.2.2. LITHOTRIPTERS
5.1.2.3. INCONTINENCE DEVICES
5.1.3. IN VITRO DIAGNOSTICS
5.1.3.1. CLINICAL CHEMISTRY
5.1.3.2. IMMUNOCHEMISTRY
5.1.3.3. MOLECULAR DIAGNOSTICS
5.1.3.4. HEMATOLOGY/HEMOSTASIS
5.1.3.5. POINT-OF-CARE TESTING
5.1.4. ORTHOPEDICS AND SPINE
5.1.4.1. RECONSTRUCTIVE IMPLANTS
5.1.4.2. SPINAL IMPLANTS
5.1.4.3. TRAUMA FIXATION DEVICES
5.1.4.4. ORTHOPEDIC ROBOTIC SYSTEMS
5.1.5. IMAGING DEVICES
5.1.5.1. X-RAY SYSTEMS
5.1.5.2. ULTRASOUND SYSTEMS
5.1.5.3. COMPUTED TOMOGRAPHY (CT)
5.1.5.4. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
5.1.5.5. CLINICAL/POINT OF CARE
5.1.5.6. NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET)
5.1.5.7. INTERVENTIONAL RADIOLOGY
5.1.5.8. LASER IMAGING
5.1.6. CARDIOVASCULAR DEVICES
5.1.6.1. CARDIAC RHYTHM MANAGEMENT
5.1.6.2. TRANSCATHETER TECHNOLOGIES
5.1.7. ENDOSCOPY
5.1.7.1. RIGID ENDOSCOPIC
5.1.7.2. FLEXIBLE ENDOSCOPIC
5.2. MARKET BY END USER 2017-2026
5.2.1. ASCS
5.2.2. HOSPITALS
5.2.3. PHYSICIANS' OFFICES
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTES
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. THREAT OF RIVALRY
6.2. VALUE CHAIN ANALYSIS
6.3. KEY BUYING CRITERIA
7. GEOGRAPHICAL ANALYSIS
7.1. ASIA PACIFIC
7.1.1. INDIA
7.1.2. CHINA
7.1.3. JAPAN
7.1.4. AUSTRALIA
7.1.5. SOUTH KOREA
8. COMPANY PROFILES
8.1. 3M COMPANY
8.1.1. COMPANY OVERVIEW
8.1.2. PRODUCT PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.2. ABBOTT LABORATORIES
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES
8.3. AGILENT TECHNOLOGIES
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. STRATEGIC INITIATIVES
8.4. BAYER
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES
8.5. BAXTER INTERNATIONAL
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.6. BECKTON, DICKINSON, AND CO.
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. STRATEGIC INITIATIVES
8.7. BOSTON SCIENTIFIC
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. STRATEGIC INITIATIVES
8.8. CARDINAL HEALTH
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. STRATEGIC INITIATIVES
8.9. CRYOLIFE INC.
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. STRATEGIC INITIATIVES
8.10. DANAHER
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.11. DEPUY SYNTHES
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. STRATEGIC INITIATIVES
8.12. ENDOLOGIX INC.
8.12.1. PRODUCT PORTFOLIO
8.12.2. STRATEGIC INITIATIVES
8.13. FRESENIUS
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. STRATEGIC INITIATIVES
8.14. GE HEALTHCARE
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. STRATEGIC INITIATIVES
8.15. HALYARD HEALTH, INC.
8.15.1. COMPANY OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. STRATEGIC INITIATIVES
8.16. JOHNSON & JOHNSON
8.16.1. COMPANY OVERVIEW
8.16.2. PRODUCT PORTFOLIO
8.16.3. STRATEGIC INITIATIVES
8.17. MEDTRONIC
8.17.1. COMPANY OVERVIEW
8.17.2. PRODUCT PORTFOLIO
8.17.3. STRATEGIC INITIATIVES
8.18. NOVARTIS
8.18.1. COMPANY OVERVIEW
8.18.2. PRODUCT PORTFOLIO
8.18.3. STRATEGIC INITIATIVES
8.19. OLYMPUS CORPORATION
8.19.1. COMPANY OVERVIEW
8.19.2. PRODUCT PORTFOLIO
8.19.3. STRATEGIC INITIATIVES
8.20. PHILIPS HEALTHCARE
8.20.1. COMPANY OVERVIEW
8.20.2. PRODUCT PORTFOLIO
8.20.3. STRATEGIC INITIATIVES
8.21. ROCHE DIAGNOSTICS
8.21.1. COMPANY OVERVIEW
8.21.2. PRODUCT PORTFOLIO
8.21.3. STRATEGIC INITIATIVES
8.22. SIEMENS HEALTHCARE
8.22.1. COMPANY OVERVIEW
8.22.2. PRODUCT PORTFOLIO
8.22.3. STRATEGIC INITIATIVES
8.23. SMITH & NEPHEW
8.23.1. COMPANY OVERVIEW
8.23.2. PRODUCT PORTFOLIO
8.23.3. STRATEGIC INITIATIVES
8.24. STRYKER CORP.
8.24.1. COMPANY OVERVIEW
8.24.2. PRODUCT PORTFOLIO
8.24.3. STRATEGIC INITIATIVES
8.25. TELEFLEX
8.25.1. COMPANY OVERVIEW
8.25.2. PRODUCT PORTFOLIO
8.25.3. STRATEGIC INITIATIVES
8.26. THERMO FISHER SCIENTIFIC
8.26.1. COMPANY OVERVIEW
8.26.2. PRODUCT PORTFOLIO
8.26.3. STRATEGIC INITIATIVES
8.27. TOSHIBA MEDICAL SYSTEMS CORP. (CANON)
8.27.1. COMPANY OVERVIEW
8.27.2. PRODUCT PORTFOLIO
8.27.3. STRATEGIC INITIATIVES
8.28. ZIMMER HOLDINGS
8.28.1. COMPANY OVERVIEW
8.28.2. PRODUCT PORTFOLIO
8.28.3. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 ASIA PACIFIC SURGICAL AND MEDICAL DEVICES MARKET 2017-2026 ($ MILLION)
TABLE 2 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET, BY TECHNOLOGY 2017-2026 ($ MILLION)
TABLE 3 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN DRUG DELIVERY DEVICES 2017-2026 ($ MILLION)
TABLE 4 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INFUSION SYSTEMS AND INJECTABLES, 2017-2026 ($ MILLION)
TABLE 5 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN NEEDLE-FREE INJECTIONS, 2017-2026 ($ MILLION)
TABLE 6 MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES
TABLE 7 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET INHALATION SYSTEMS, 2017-2026 ($ MILLION)
TABLE 8 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN UROLOGY AND RENAL 2017-2026 ($ MILLION)
TABLE 9 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RENAL DIALYSIS DEVICES, 2017-2026 ($ MILLION)
TABLE 10 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN LITHOTRIPTERS, 2017-2026 ($ MILLION)
TABLE 11 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INCONTINENCE DEVICES, 2017-2026 ($ MILLION)
TABLE 12 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
TABLE 13 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL CHEMISTRY 2017-2026 ($ MILLION)
TABLE 14 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN IMMUNOCHEMISTRY 2017-2026 ($ MILLION)
TABLE 15 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN MOLECULAR DIAGNOSTICS 2017-2026 ($ MILLION)
TABLE 16 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN HEMATOLOGY/HEMOSTASIS 2017-2026 ($ MILLION)
TABLE 17 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN POINT-OF-CARE TESTING 2017-2026 ($ MILLION)
TABLE 18 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPAEDICS AND SPINE 2017-2026 ($ MILLION)
TABLE 19 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RECONSTRUCTIVE IMPLANTS 2017-2026 ($ MILLION)
TABLE 20 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN SPINAL IMPLANTS 2017-2026 ($ MILLION)
TABLE 21 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN TRAUMA FIXATION DEVICES 2017-2026 ($ MILLION)
TABLE 22 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPEDIC ROBOTIC SYSTEMS 2017-2026 ($ MILLION)
TABLE 23 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN IMAGING DEVICES 2017-2026 ($ MILLION)
TABLE 24 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN X-RAY SYSTEMS 2017-2026 ($ MILLION)
TABLE 25 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ULTRASOUND SYSTEMS 2017-2026 ($ MILLION)
TABLE 26 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN COMPUTED TOMOGRAPHY (CT) 2017-2026 ($ MILLION)
TABLE 27 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 2017-2026 ($ MILLION)
TABLE 28 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL/POINT OF CARE 2017-2026 ($ MILLION)
TABLE 29 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET) 2017-2026 ($ MILLION)
TABLE 30 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INTERVENTIONAL RADIOLOGY 2017-2026 ($ MILLION)
TABLE 31 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
TABLE 32 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CARDIOVASCULAR DEVICES 2017-2026 ($ MILLION)
TABLE 33 ABLATION TYPES AND THEIR MECHANISMS
TABLE 34 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CARDIAC RHYTHM MANAGEMENT 2017-2026 ($ MILLION)
TABLE 35 ANTI-ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE
TABLE 36 ANTI-ARRHYTHMIC DRUG CLASSIFICATION AND CLINICAL USAGE
TABLE 37 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN TRANSCATHETER TECHNOLOGIES 2017-2026 ($ MILLION)
TABLE 38 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ENDOSCOPY 2017-2026 ($ MILLION)
TABLE 39 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RIGID ENDOSCOPIC 2017-2026 ($ MILLION)
TABLE 40 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN FLEXIBLE ENDOSCOPIC 2017-2026 ($ MILLION)
TABLE 41 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET, BY END-USER 2017-2026 ($MILLION)
TABLE 42 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ASCS, 2017-2026 ($MILLION)
TABLE 43 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN HOSPITAL, 2017-2026 ($MILLION)
TABLE 44 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN PHYSICIANS OFFICES, 2017-2026 ($MILLION)
TABLE 45 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET, BY COUNTRIES 2017-2026 ($ MILLION)
FIGURE LIST
FIGURE 1 ASIA PACIFIC SURGICAL AND MEDICAL DEVICES MARKET 2017-2026 ($ MILLION)
FIGURE 2 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN DRUG DELIVERY DEVICES 2017-2026 ($ MILLION)
FIGURE 3 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INFUSION SYSTEMS AND INJECTABLES 2017-2026 ($ MILLION)
FIGURE 4 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN NEEDLE-FREE INJECTIONS 2017-2026 ($ MILLION)
FIGURE 5 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INHALATION SYSTEMS 2017-2026 ($ MILLION)
FIGURE 6 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN UROLOGY AND RENAL 2017-2026 ($ MILLION)
FIGURE 7 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RENAL DIALYSIS DEVICES 2017-2026 ($ MILLION)
FIGURE 8 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN LITHOTRIPTERS 2017-2026 ($ MILLION)
FIGURE 9 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INCONTINENCE DEVICES 2017-2026 ($ MILLION)
FIGURE 10 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 11 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL CHEMISTRY 2017-2026 ($ MILLION)
FIGURE 12 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN IMMUNOCHEMISTRY 2017-2026 ($ MILLION)
FIGURE 13 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN MOLECULAR DIAGNOSTICS 2017-2026 ($ MILLION)
FIGURE 14 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN HEMATOLOGY/HEMOSTASIS 2017-2026 ($ MILLION)
FIGURE 15 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN POINT-OF-CARE TESTING 2017-2026 ($ MILLION)
FIGURE 16 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPAEDICS AND SPINE 2017-2026 ($ MILLION)
FIGURE 17 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RECONSTRUCTIVE IMPLANTS 2017-2026 ($ MILLION)
FIGURE 18 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN SPINAL IMPLANTS 2017-2026 ($ MILLION)
FIGURE 19 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN TRAUMA FIXATION DEVICES 2017-2026 ($ MILLION)
FIGURE 20 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPEDIC ROBOTIC SYSTEMS 2017-2026 ($ MILLION)
FIGURE 21 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN IMAGING DEVICES 2017-2026 ($ MILLION)
FIGURE 22 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN X-RAY SYSTEMS 2017-2026 ($ MILLION)
FIGURE 23 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ULTRASOUND SYSTEMS 2017-2026 ($ MILLION)
FIGURE 24 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN COMPUTED TOMOGRAPHY (CT) 2017-2026 ($ MILLION)
FIGURE 25 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 2017-2026 ($ MILLION)
FIGURE 26 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL/POINT OF CARE 2017-2026 ($ MILLION)
FIGURE 27 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET) 2017-2026 ($ MILLION)
FIGURE 28 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INTERVENTIONAL RADIOLOGY 2017-2026 ($ MILLION)
FIGURE 29 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 30 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CARDIOVASCULAR DEVICES 2017-2026 ($ MILLION)
FIGURE 31 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CARDIAC RHYTHM MANAGEMENT 2017-2026 ($ MILLION)
FIGURE 32 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN TRANSCATHETER TECHNOLOGIES 2017-2026 ($ MILLION)
FIGURE 33 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ENDOSCOPY 2017-2026 ($ MILLION)
FIGURE 34 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RIGID ENDOSCOPIC 2017-2026 ($ MILLION)
FIGURE 35 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN FLEXIBLE ENDOSCOPIC 2017-2026 ($ MILLION)
FIGURE 36 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ASCS 2017-2026 ($MILLION)
FIGURE 37 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN HOSPITAL 2017-2026 ($MILLION)
FIGURE 38 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN PHYSICIANS OFFICES 2017-2026 ($MILLION)
FIGURE 39 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 40 INDIA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 41 CHINA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 42 JAPAN SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 43 AUSTRALIA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 44 SOUTH KOREA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
COMPANIES MENTIONED
1. 3M COMPANY
2. ABBOTT LABORATORIES
3. AGILENT TECHNOLOGIES
4. BAYER
5. BAXTER INTERNATIONAL
6. BECKTON, DICKINSON, AND CO.
7. BOSTON SCIENTIFIC
8. CARDINAL HEALTH
9. CRYOLIFE INC.
10. DANAHER
11. DEPUY SYNTHES
12. ENDOLOGIX INC.
13. FRESENIUS
14. GE HEALTHCARE
15. HALYARD HEALTH, INC.
16. JOHNSON & JOHNSON
17. MEDTRONIC
18. NOVARTIS
19. OLYMPUS CORPORATION
20. PHILIPS HEALTHCARE
21. ROCHE DIAGNOSTICS
22. SIEMENS HEALTHCARE
23. SMITH & NEPHEW
24. STRYKER CORP.
25. TELEFLEX
26. THERMO FISHER SCIENTIFIC
27. TOSHIBA MEDICAL SYSTEMS CORP. (CANON)
28. ZIMMER HOLDINGS
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. DRUG DELIVERY DEVICES HOLDS THE LARGEST MARKET SHARE IN TERMS OF TECHNOLOGY
3.2.2. AMBULATORY SURGERY CENTERS (ASC) ARE THE MARKET LEADERS IN TERMS OF END USERS
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. PROLONGED LIFE EXPECTANCY
4.1.2. INCREASE IN DEMAND FOR MEDICAL DEVICE TECHNOLOGIES
4.1.3. LEGISLATIVE ALTERATIONS AND OTHER INGENUITIES
4.2. MARKET RESTRAINTS
4.2.1. HIGH COSTS OF MEDICAL AND SURGICAL DEVICES
4.2.2. EXCISE DUTY ADDED TO THE COST OF MEDICAL DEVICES
5. MARKET SEGMENTATION
5.1. MARKET BY TECHNOLOGY 2017-2026
5.1.1. DRUG DELIVERY DEVICES
5.1.1.1. INFUSION SYSTEMS AND INJECTABLE
5.1.1.2. NEEDLE-FREE INJECTIONS/TRANSDERMAL SYSTEMS AND OTHERS
5.1.1.3. INHALATION SYSTEMS
5.1.2. UROLOGY AND RENAL
5.1.2.1. RENAL DIALYSIS DEVICES
5.1.2.2. LITHOTRIPTERS
5.1.2.3. INCONTINENCE DEVICES
5.1.3. IN VITRO DIAGNOSTICS
5.1.3.1. CLINICAL CHEMISTRY
5.1.3.2. IMMUNOCHEMISTRY
5.1.3.3. MOLECULAR DIAGNOSTICS
5.1.3.4. HEMATOLOGY/HEMOSTASIS
5.1.3.5. POINT-OF-CARE TESTING
5.1.4. ORTHOPEDICS AND SPINE
5.1.4.1. RECONSTRUCTIVE IMPLANTS
5.1.4.2. SPINAL IMPLANTS
5.1.4.3. TRAUMA FIXATION DEVICES
5.1.4.4. ORTHOPEDIC ROBOTIC SYSTEMS
5.1.5. IMAGING DEVICES
5.1.5.1. X-RAY SYSTEMS
5.1.5.2. ULTRASOUND SYSTEMS
5.1.5.3. COMPUTED TOMOGRAPHY (CT)
5.1.5.4. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
5.1.5.5. CLINICAL/POINT OF CARE
5.1.5.6. NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET)
5.1.5.7. INTERVENTIONAL RADIOLOGY
5.1.5.8. LASER IMAGING
5.1.6. CARDIOVASCULAR DEVICES
5.1.6.1. CARDIAC RHYTHM MANAGEMENT
5.1.6.2. TRANSCATHETER TECHNOLOGIES
5.1.7. ENDOSCOPY
5.1.7.1. RIGID ENDOSCOPIC
5.1.7.2. FLEXIBLE ENDOSCOPIC
5.2. MARKET BY END USER 2017-2026
5.2.1. ASCS
5.2.2. HOSPITALS
5.2.3. PHYSICIANS' OFFICES
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTES
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. THREAT OF RIVALRY
6.2. VALUE CHAIN ANALYSIS
6.3. KEY BUYING CRITERIA
7. GEOGRAPHICAL ANALYSIS
7.1. ASIA PACIFIC
7.1.1. INDIA
7.1.2. CHINA
7.1.3. JAPAN
7.1.4. AUSTRALIA
7.1.5. SOUTH KOREA
8. COMPANY PROFILES
8.1. 3M COMPANY
8.1.1. COMPANY OVERVIEW
8.1.2. PRODUCT PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.2. ABBOTT LABORATORIES
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES
8.3. AGILENT TECHNOLOGIES
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. STRATEGIC INITIATIVES
8.4. BAYER
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES
8.5. BAXTER INTERNATIONAL
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.6. BECKTON, DICKINSON, AND CO.
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. STRATEGIC INITIATIVES
8.7. BOSTON SCIENTIFIC
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. STRATEGIC INITIATIVES
8.8. CARDINAL HEALTH
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. STRATEGIC INITIATIVES
8.9. CRYOLIFE INC.
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. STRATEGIC INITIATIVES
8.10. DANAHER
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.11. DEPUY SYNTHES
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. STRATEGIC INITIATIVES
8.12. ENDOLOGIX INC.
8.12.1. PRODUCT PORTFOLIO
8.12.2. STRATEGIC INITIATIVES
8.13. FRESENIUS
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. STRATEGIC INITIATIVES
8.14. GE HEALTHCARE
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. STRATEGIC INITIATIVES
8.15. HALYARD HEALTH, INC.
8.15.1. COMPANY OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. STRATEGIC INITIATIVES
8.16. JOHNSON & JOHNSON
8.16.1. COMPANY OVERVIEW
8.16.2. PRODUCT PORTFOLIO
8.16.3. STRATEGIC INITIATIVES
8.17. MEDTRONIC
8.17.1. COMPANY OVERVIEW
8.17.2. PRODUCT PORTFOLIO
8.17.3. STRATEGIC INITIATIVES
8.18. NOVARTIS
8.18.1. COMPANY OVERVIEW
8.18.2. PRODUCT PORTFOLIO
8.18.3. STRATEGIC INITIATIVES
8.19. OLYMPUS CORPORATION
8.19.1. COMPANY OVERVIEW
8.19.2. PRODUCT PORTFOLIO
8.19.3. STRATEGIC INITIATIVES
8.20. PHILIPS HEALTHCARE
8.20.1. COMPANY OVERVIEW
8.20.2. PRODUCT PORTFOLIO
8.20.3. STRATEGIC INITIATIVES
8.21. ROCHE DIAGNOSTICS
8.21.1. COMPANY OVERVIEW
8.21.2. PRODUCT PORTFOLIO
8.21.3. STRATEGIC INITIATIVES
8.22. SIEMENS HEALTHCARE
8.22.1. COMPANY OVERVIEW
8.22.2. PRODUCT PORTFOLIO
8.22.3. STRATEGIC INITIATIVES
8.23. SMITH & NEPHEW
8.23.1. COMPANY OVERVIEW
8.23.2. PRODUCT PORTFOLIO
8.23.3. STRATEGIC INITIATIVES
8.24. STRYKER CORP.
8.24.1. COMPANY OVERVIEW
8.24.2. PRODUCT PORTFOLIO
8.24.3. STRATEGIC INITIATIVES
8.25. TELEFLEX
8.25.1. COMPANY OVERVIEW
8.25.2. PRODUCT PORTFOLIO
8.25.3. STRATEGIC INITIATIVES
8.26. THERMO FISHER SCIENTIFIC
8.26.1. COMPANY OVERVIEW
8.26.2. PRODUCT PORTFOLIO
8.26.3. STRATEGIC INITIATIVES
8.27. TOSHIBA MEDICAL SYSTEMS CORP. (CANON)
8.27.1. COMPANY OVERVIEW
8.27.2. PRODUCT PORTFOLIO
8.27.3. STRATEGIC INITIATIVES
8.28. ZIMMER HOLDINGS
8.28.1. COMPANY OVERVIEW
8.28.2. PRODUCT PORTFOLIO
8.28.3. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 ASIA PACIFIC SURGICAL AND MEDICAL DEVICES MARKET 2017-2026 ($ MILLION)
TABLE 2 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET, BY TECHNOLOGY 2017-2026 ($ MILLION)
TABLE 3 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN DRUG DELIVERY DEVICES 2017-2026 ($ MILLION)
TABLE 4 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INFUSION SYSTEMS AND INJECTABLES, 2017-2026 ($ MILLION)
TABLE 5 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN NEEDLE-FREE INJECTIONS, 2017-2026 ($ MILLION)
TABLE 6 MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES
TABLE 7 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET INHALATION SYSTEMS, 2017-2026 ($ MILLION)
TABLE 8 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN UROLOGY AND RENAL 2017-2026 ($ MILLION)
TABLE 9 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RENAL DIALYSIS DEVICES, 2017-2026 ($ MILLION)
TABLE 10 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN LITHOTRIPTERS, 2017-2026 ($ MILLION)
TABLE 11 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INCONTINENCE DEVICES, 2017-2026 ($ MILLION)
TABLE 12 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
TABLE 13 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL CHEMISTRY 2017-2026 ($ MILLION)
TABLE 14 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN IMMUNOCHEMISTRY 2017-2026 ($ MILLION)
TABLE 15 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN MOLECULAR DIAGNOSTICS 2017-2026 ($ MILLION)
TABLE 16 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN HEMATOLOGY/HEMOSTASIS 2017-2026 ($ MILLION)
TABLE 17 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN POINT-OF-CARE TESTING 2017-2026 ($ MILLION)
TABLE 18 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPAEDICS AND SPINE 2017-2026 ($ MILLION)
TABLE 19 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RECONSTRUCTIVE IMPLANTS 2017-2026 ($ MILLION)
TABLE 20 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN SPINAL IMPLANTS 2017-2026 ($ MILLION)
TABLE 21 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN TRAUMA FIXATION DEVICES 2017-2026 ($ MILLION)
TABLE 22 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPEDIC ROBOTIC SYSTEMS 2017-2026 ($ MILLION)
TABLE 23 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN IMAGING DEVICES 2017-2026 ($ MILLION)
TABLE 24 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN X-RAY SYSTEMS 2017-2026 ($ MILLION)
TABLE 25 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ULTRASOUND SYSTEMS 2017-2026 ($ MILLION)
TABLE 26 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN COMPUTED TOMOGRAPHY (CT) 2017-2026 ($ MILLION)
TABLE 27 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 2017-2026 ($ MILLION)
TABLE 28 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL/POINT OF CARE 2017-2026 ($ MILLION)
TABLE 29 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET) 2017-2026 ($ MILLION)
TABLE 30 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INTERVENTIONAL RADIOLOGY 2017-2026 ($ MILLION)
TABLE 31 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
TABLE 32 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CARDIOVASCULAR DEVICES 2017-2026 ($ MILLION)
TABLE 33 ABLATION TYPES AND THEIR MECHANISMS
TABLE 34 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CARDIAC RHYTHM MANAGEMENT 2017-2026 ($ MILLION)
TABLE 35 ANTI-ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE
TABLE 36 ANTI-ARRHYTHMIC DRUG CLASSIFICATION AND CLINICAL USAGE
TABLE 37 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN TRANSCATHETER TECHNOLOGIES 2017-2026 ($ MILLION)
TABLE 38 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ENDOSCOPY 2017-2026 ($ MILLION)
TABLE 39 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RIGID ENDOSCOPIC 2017-2026 ($ MILLION)
TABLE 40 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN FLEXIBLE ENDOSCOPIC 2017-2026 ($ MILLION)
TABLE 41 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET, BY END-USER 2017-2026 ($MILLION)
TABLE 42 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ASCS, 2017-2026 ($MILLION)
TABLE 43 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN HOSPITAL, 2017-2026 ($MILLION)
TABLE 44 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN PHYSICIANS OFFICES, 2017-2026 ($MILLION)
TABLE 45 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET, BY COUNTRIES 2017-2026 ($ MILLION)
FIGURE LIST
FIGURE 1 ASIA PACIFIC SURGICAL AND MEDICAL DEVICES MARKET 2017-2026 ($ MILLION)
FIGURE 2 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN DRUG DELIVERY DEVICES 2017-2026 ($ MILLION)
FIGURE 3 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INFUSION SYSTEMS AND INJECTABLES 2017-2026 ($ MILLION)
FIGURE 4 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN NEEDLE-FREE INJECTIONS 2017-2026 ($ MILLION)
FIGURE 5 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INHALATION SYSTEMS 2017-2026 ($ MILLION)
FIGURE 6 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN UROLOGY AND RENAL 2017-2026 ($ MILLION)
FIGURE 7 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RENAL DIALYSIS DEVICES 2017-2026 ($ MILLION)
FIGURE 8 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN LITHOTRIPTERS 2017-2026 ($ MILLION)
FIGURE 9 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INCONTINENCE DEVICES 2017-2026 ($ MILLION)
FIGURE 10 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 11 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL CHEMISTRY 2017-2026 ($ MILLION)
FIGURE 12 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN IMMUNOCHEMISTRY 2017-2026 ($ MILLION)
FIGURE 13 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN MOLECULAR DIAGNOSTICS 2017-2026 ($ MILLION)
FIGURE 14 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN HEMATOLOGY/HEMOSTASIS 2017-2026 ($ MILLION)
FIGURE 15 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN POINT-OF-CARE TESTING 2017-2026 ($ MILLION)
FIGURE 16 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPAEDICS AND SPINE 2017-2026 ($ MILLION)
FIGURE 17 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RECONSTRUCTIVE IMPLANTS 2017-2026 ($ MILLION)
FIGURE 18 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN SPINAL IMPLANTS 2017-2026 ($ MILLION)
FIGURE 19 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN TRAUMA FIXATION DEVICES 2017-2026 ($ MILLION)
FIGURE 20 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPEDIC ROBOTIC SYSTEMS 2017-2026 ($ MILLION)
FIGURE 21 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN IMAGING DEVICES 2017-2026 ($ MILLION)
FIGURE 22 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN X-RAY SYSTEMS 2017-2026 ($ MILLION)
FIGURE 23 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ULTRASOUND SYSTEMS 2017-2026 ($ MILLION)
FIGURE 24 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN COMPUTED TOMOGRAPHY (CT) 2017-2026 ($ MILLION)
FIGURE 25 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 2017-2026 ($ MILLION)
FIGURE 26 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL/POINT OF CARE 2017-2026 ($ MILLION)
FIGURE 27 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET) 2017-2026 ($ MILLION)
FIGURE 28 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN INTERVENTIONAL RADIOLOGY 2017-2026 ($ MILLION)
FIGURE 29 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 30 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CARDIOVASCULAR DEVICES 2017-2026 ($ MILLION)
FIGURE 31 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN CARDIAC RHYTHM MANAGEMENT 2017-2026 ($ MILLION)
FIGURE 32 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN TRANSCATHETER TECHNOLOGIES 2017-2026 ($ MILLION)
FIGURE 33 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ENDOSCOPY 2017-2026 ($ MILLION)
FIGURE 34 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN RIGID ENDOSCOPIC 2017-2026 ($ MILLION)
FIGURE 35 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN FLEXIBLE ENDOSCOPIC 2017-2026 ($ MILLION)
FIGURE 36 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN ASCS 2017-2026 ($MILLION)
FIGURE 37 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN HOSPITAL 2017-2026 ($MILLION)
FIGURE 38 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN PHYSICIANS OFFICES 2017-2026 ($MILLION)
FIGURE 39 ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 40 INDIA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 41 CHINA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 42 JAPAN SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 43 AUSTRALIA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 44 SOUTH KOREA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
COMPANIES MENTIONED
1. 3M COMPANY
2. ABBOTT LABORATORIES
3. AGILENT TECHNOLOGIES
4. BAYER
5. BAXTER INTERNATIONAL
6. BECKTON, DICKINSON, AND CO.
7. BOSTON SCIENTIFIC
8. CARDINAL HEALTH
9. CRYOLIFE INC.
10. DANAHER
11. DEPUY SYNTHES
12. ENDOLOGIX INC.
13. FRESENIUS
14. GE HEALTHCARE
15. HALYARD HEALTH, INC.
16. JOHNSON & JOHNSON
17. MEDTRONIC
18. NOVARTIS
19. OLYMPUS CORPORATION
20. PHILIPS HEALTHCARE
21. ROCHE DIAGNOSTICS
22. SIEMENS HEALTHCARE
23. SMITH & NEPHEW
24. STRYKER CORP.
25. TELEFLEX
26. THERMO FISHER SCIENTIFIC
27. TOSHIBA MEDICAL SYSTEMS CORP. (CANON)
28. ZIMMER HOLDINGS
